Sign in
New Biomarkers of Angiogenesis in AMD Using OCT Angiography
David Sarraf, MD
Updates from the Field
2017
A Real-World Analysis in 49,485 Eyes of Visual Acuity Outcomes and Anti-VEGF Therapy Intensity in Neovascular AMD Patients
David F. Williams, MD, MBA
Annual Meeting Talks
2018
Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER
Arshad M. Khanani, MD, MA, FASRS
Category: Imaging – Digital-Fluorescein angiography